Angiopoietin-like-4 and minimal change disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Angiopoietin-like-4 and minimal change disease

Published:2017-04-25 Issue:4 Volume:12 Page:e0176198
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cara-Fuentes Gabriel,Segarra Alfons,Silva-Sanchez Cecilia,Wang Heiman,Lanaspa Miguel A.,Johnson Richard J.,Garin Eduardo H.

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children;J Pediatr,1981

2. Pathogenesis of lipoid nephrosis: a disorder of T-cell function;RJ Shalhoub;Lancet,1974

3. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome;CE Araya;Pediatr Nephrol,2006

4. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome;LC Clement;Nat Med,2011

5. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome;LC Clement;Nat Med,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Podocyte-targeted therapies — progress and future directions;Nature Reviews Nephrology;2024-05-09

2. Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis;Frontiers in Immunology;2023-09-19

3. Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response;IRAN J IMMUNOL;2023

4. Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?;Clinical Kidney Journal;2023-05-24

5. Expression of Angiopoetin-Like Protein-4 and Kidney Injury Molecule-1 as Preliminary Diagnostic Markers for Diabetes-Related Kidney Disease: A Single Center-Based Cross-Sectional Study;Journal of Personalized Medicine;2023-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3